Search research articles
Contact Us
Filters
Showing results (641-650 of 1,095) with videos related to
Page
of 110
Sort By:
The Lancet. Gastroenterology & Hepatology
|
May 23, 2025
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles
Lindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Infection and Drug Resistance
|
December 7, 2018
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
Celia Perales, Qian Chen, Maria Eugenia Soria, et al.
The Journal of General Virology
|
December 15, 2017
New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors
Laura Ordeig, Damir Garcia-Cehic, Josep Gregori, et al.
Alimentary Pharmacology & Therapeutics
|
November 30, 2016
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)
M Buti, J L Calleja, S Lens, et al.
European Journal of Oral Implantology
|
June 4, 2014
Surgical treatment of single gingival recessions: clinical guidelines
Giovanpaolo Pini-Prato, Michele Nieri, Umberto Pagliaro, et al.
Journal of Hepatology
|
July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide
Maria Buti, Heiner Wedemeyer, Soo Aleman, et al.
Diagnostic Cytopathology
|
July 9, 2015
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients
Cecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, et al.
Journal of Hepatology
|
April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Xavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 14, 2025
Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg-Negative Caucasian Patients
Anna Pocurull, Teresa Broquetas, Elena Hoyas, et al.
Clinical Genitourinary Cancer
|
November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Page
of 110
Search research articles
Search
Showing results (641-650 of 1,095) with videos related to
Sort By:
Page
of 110
The Lancet. Gastroenterology & Hepatology
|
May 23, 2025
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles
Lindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Infection and Drug Resistance
|
December 7, 2018
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
Celia Perales, Qian Chen, Maria Eugenia Soria, et al.
The Journal of General Virology
|
December 15, 2017
New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors
Laura Ordeig, Damir Garcia-Cehic, Josep Gregori, et al.
Alimentary Pharmacology & Therapeutics
|
November 30, 2016
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)
M Buti, J L Calleja, S Lens, et al.
European Journal of Oral Implantology
|
June 4, 2014
Surgical treatment of single gingival recessions: clinical guidelines
Giovanpaolo Pini-Prato, Michele Nieri, Umberto Pagliaro, et al.
Journal of Hepatology
|
July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide
Maria Buti, Heiner Wedemeyer, Soo Aleman, et al.
Diagnostic Cytopathology
|
July 9, 2015
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients
Cecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, et al.
Journal of Hepatology
|
April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Xavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 14, 2025
Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg-Negative Caucasian Patients
Anna Pocurull, Teresa Broquetas, Elena Hoyas, et al.
Clinical Genitourinary Cancer
|
November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Page
of 110